Related Experiment Video
Updated: Aug 22, 2025

07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
6.6K
Modelling cutaneous squamous cell carcinoma for laboratory research
1Department of Biochemistry and Molecular Biology, Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Experimental Dermatology
|November 14, 2022
Summary
Understanding cutaneous squamous cell carcinoma (cSCC) progression requires better preclinical models. This review evaluates current models like tissue cultures and animal xenografts for studying cSCC invasion and metastasis.
Area of Science:
- Oncology
- Translational Research
- Dermatology
Background:
- Cutaneous squamous cell carcinoma (cSCC) causes significant patient morbidity due to its potential for progression and metastasis.
- The molecular mechanisms driving cSCC pathogenesis remain incompletely understood.
- There is a critical need for preclinical models that accurately replicate cSCC invasion and nodal spread.
Purpose of the Study:
- To review and analyze existing preclinical models for cutaneous squamous cell carcinoma.
- To assess the utility of various models in recapitulating key hallmarks of cSCC, including invasion and metastasis.
- To discuss the advantages, limitations, and future directions for cSCC preclinical modeling.
Main Methods:
- Review of current literature on cSCC preclinical models.
- Categorization of models including 2D/3D tissue cultures, syngeneic mice, transgenic mice, and xenografts (cell line-derived and patient-derived).
- Analysis of studies utilizing these models to evaluate their recapitulation of cSCC hallmarks.
Main Results:
- Various models exist, each with specific strengths and weaknesses in mimicking cSCC.
- Tissue cultures, syngeneic/transgenic mice, and xenografts offer different levels of complexity and relevance.
- Model selection impacts the ability to study specific aspects of cSCC, such as invasion and metastasis.
Conclusions:
- No single model perfectly recapitulates all aspects of human cSCC.
- Patient-derived xenografts and advanced 3D cultures show promise for modeling invasion and metastasis.
- Further development and strategic use of diverse preclinical models are essential for advancing cSCC research and therapy.

